| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/20/2000 | CA2360366A1 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections |
| 07/20/2000 | CA2360243A1 Use of lactobacillus salivarius |
| 07/20/2000 | CA2360060A1 Steroid derived antibiotics |
| 07/20/2000 | CA2359504A1 Novel compounds |
| 07/20/2000 | CA2359486A1 Neisseria meningitidis polypeptide basb052 |
| 07/20/2000 | CA2359479A1 Novel complex-forming proteins |
| 07/20/2000 | CA2359478A1 Administration of an anti-endotoxin drug by intravenous infusion |
| 07/20/2000 | CA2359110A1 Combination of hepatitis b vaccine with antiviral agents |
| 07/20/2000 | CA2358684A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | CA2356939A1 Modulation of systemic memory t cell trafficking |
| 07/20/2000 | CA2355374A1 1-heterocycle substituted diarylamines |
| 07/20/2000 | CA2353088A1 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors |
| 07/20/2000 | CA2349832A1 Benzenesulfonamide derivatives and their use as mek inhibitors |
| 07/20/2000 | CA2349467A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 07/20/2000 | CA2349180A1 Anthranilic acid derivatives |
| 07/20/2000 | CA2348236A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
| 07/19/2000 | EP1020516A2 Leptospira vaccine antigens for the prevention of leptospirosis |
| 07/19/2000 | EP1020474A1 Oligosaccharide derivatives and process for producing the same |
| 07/19/2000 | EP1020471A1 Process for producing UCN-01 |
| 07/19/2000 | EP1020461A2 Use of alkaline salts of the (-)-enantiomer of omeprazole |
| 07/19/2000 | EP1020460A2 The sodium salt of the (-)-enantiomer of omeprazole |
| 07/19/2000 | EP1020426A1 Amine derivatives and process for producing the same |
| 07/19/2000 | EP1020179A2 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 07/19/2000 | EP1019726A1 Prevention of sudden infant death |
| 07/19/2000 | EP1019522A1 Compositions and methods for administering pneumococcal dna |
| 07/19/2000 | EP1019431A1 Novel rnase p |
| 07/19/2000 | EP1019425A1 Modified benzimidazole nucleosides as antiviral agents |
| 07/19/2000 | EP1019405A1 Beta-methylcarbapenem derivatives, process for the preparation thereof and pharmaceutical composition comprising same |
| 07/19/2000 | EP1019404A1 Purine acyclonucleosides as antiviral agents |
| 07/19/2000 | EP1019396A1 Novel cycloalkyl substituted imidazoles |
| 07/19/2000 | EP1019385A1 Aminoaryl oxazolidinone n-oxides |
| 07/19/2000 | EP1019382A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
| 07/19/2000 | EP1019380A2 Tricyclic 3-oxo-propanenitrile compounds |
| 07/19/2000 | EP1019091A1 50 human secreted proteins |
| 07/19/2000 | EP1019089A2 Long-acting drugs and pharmaceutical compositions comprising them |
| 07/19/2000 | EP1019084A1 Novel antimicrobial polypeptide and methods of use |
| 07/19/2000 | EP1019083A1 Methods and compositions for the selective modification of nucleic acids |
| 07/19/2000 | EP1019081A2 Apolipoprotein e/growth factor complexes and methods of use |
| 07/19/2000 | EP1019076A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 07/19/2000 | EP1019061A1 Urease-responsive delivery systems for diagnostic and therapeutic applications |
| 07/19/2000 | EP1019058A1 Pharmaceutical suspension comprising nevirapine hemihydrate |
| 07/19/2000 | EP1019056A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89 |
| 07/19/2000 | EP1019040A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS |
| 07/19/2000 | EP1019028A1 $i(CHLAMYDIA) PROTEIN, GENE SEQUENCE AND USES THEREOF |
| 07/19/2000 | EP1019010A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 07/19/2000 | EP1019006A1 Apparatus for the application of ozone/oxygen for the treatment of external pathogenic conditions |
| 07/19/2000 | EP0902781A4 Preparation of (s)-decahydroisoquinoline-3-carboxylic acid t-butylamide |
| 07/19/2000 | EP0752989B1 Thiazolylpyrazolinones and their use for protecting technical materials |
| 07/19/2000 | CN1260796A Alkaloid halide salts of swainsonine and methods of use |
| 07/19/2000 | CN1260784A Quinoline derivatives as PDEIV and INF inhibitors |
| 07/19/2000 | CN1260723A Oil in water vaccine composition |
| 07/19/2000 | CN1260703A Drug delivery device and method for treating viral and microbial infections and wasting syndromes |
| 07/19/2000 | CN1260207A Medicinal powder for pulmonary tuberculosis |
| 07/19/2000 | CN1260199A Multifunction quick-effect health medicinal plaster |
| 07/19/2000 | CN1260175A Compound aminoacyl damobin calcium tablet |
| 07/19/2000 | CN1260174A Liquid preparation containing norfloxacin and metronidazole |
| 07/19/2000 | CN1054606C Process for preparing anti-virus chemical compound-Babaosu |
| 07/19/2000 | CN1054598C Pharmacalogically active hydrazine derivatives and process for preparation thereof |
| 07/19/2000 | CN1054509C Synergistic interplay of lymphokines and dsRNAs |
| 07/19/2000 | CN1054508C Method for preparing pharmaceutical composition |
| 07/19/2000 | CN1054507C Preparation method for medicinal composition for treatment of vaginal infections |
| 07/19/2000 | CN1054506C Pharmaceutical composition use |
| 07/18/2000 | US6090944 Alkanoic acid derivatives as αv integrin receptor antagonists |
| 07/18/2000 | US6090941 Pharmaceutically active benzoquinazoline compounds |
| 07/18/2000 | US6090932 Method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 07/18/2000 | US6090914 CTLA4/CD28Ig hybrid fusion proteins and uses thereof |
| 07/18/2000 | US6090821 Substituted quinolin-2 (1H)-ones useful as HIV reverse transcriptase inhibitors |
| 07/18/2000 | US6090820 Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones |
| 07/18/2000 | US6090813 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 07/18/2000 | US6090801 Pharmaceutical compositions containing ceftriaxone and penems |
| 07/18/2000 | US6090788 Irradiating the area of skin or nail with a light beam having at least one wavelength absorbable by the pathogen to destruct the fungal pathogen |
| 07/18/2000 | US6090782 Contacting hematopoietic cells with a stem cell proliferation inhibition amount of a peptide or polypeptide having specific amino acid sequence |
| 07/18/2000 | US6090611 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 07/18/2000 | US6090586 66 kDa antigen from Borrelia |
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090392 Genetic engineering; culture product |
| 07/18/2000 | US6090391 Recombinant tryptophan mutants of influenza |
| 07/18/2000 | US6090390 Diagnostic test for equine arteritis virus mediated disease |
| 07/18/2000 | US6090388 Peptide composition for prevention and treatment of HIV infection and immune disorders |
| 07/18/2000 | US6090382 Human antibodies that bind human TNFα |
| 07/18/2000 | CA2148651C Halogenated antifungal and antibacterial compounds used for reducing hair loss |
| 07/18/2000 | CA2132933C Soft gelatin capsule manufacture |
| 07/18/2000 | CA2129051C Absorbable composite materials for use in the treatment of periodontal disease |
| 07/18/2000 | CA2108777C Modified plant viruses as vectors |
| 07/18/2000 | CA2006716C Antibacterial antiplaque oral composition |
| 07/18/2000 | CA1341055C Transfectant cell lines which express the major human rhinovirus receptor |
| 07/13/2000 | WO2000040742A1 Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 07/13/2000 | WO2000040733A1 Human cyclic nucleotide pdes |
| 07/13/2000 | WO2000040729A1 Streptococcal abc transporter protein |
| 07/13/2000 | WO2000040716A2 Soluble receptor br43x2 and methods of using them for therapy |
| 07/13/2000 | WO2000040714A2 Therapeutic phosphodiesterase inhibitors |
| 07/13/2000 | WO2000040612A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040605A2 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids |
| 07/13/2000 | WO2000040597A1 Method and composition for angiogenesis inhibition |
| 07/13/2000 | WO2000040592A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof |
| 07/13/2000 | WO2000040591A1 Protonated/acidified nucleic acids and methods of use |
| 07/13/2000 | WO2000040589A2 Novel derivatives from the class of oleandomycin |
| 07/13/2000 | WO2000040576A2 Thiopyran compounds as inhibitors of mmp |
| 07/13/2000 | WO2000040574A1 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments |
| 07/13/2000 | WO2000040563A1 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |